pamidronate has been researched along with Kidney Diseases in 10 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pamidronate can rarely cause (collapsing) focal segmental glomerular sclerosis with the nephrotic syndrome and renal insufficiency." | 4.88 | Renal complications from bisphosphonate treatment. ( Hirschberg, R, 2012) |
| "Pamidronate was comparable to alendronate in prevention of early bone loss after kidney transplantation." | 2.76 | Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation. ( Alasti, M; Beladi Mousavi, SS; Ghorbani, A; Omidvar, B; Shahbazian, H; Shariat Nabavi, SJ, 2011) |
| "Collapsing focal segmental glomerulosclerosis is well described in its idiopathic form, mostly seen in young African American patients, and in association with HIV virus." | 2.45 | [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review]. ( Jotterand, V; Martin, PY; Moll, S; Saudan, P, 2009) |
| " Patterns of nephrotoxicity described with these agents include toxic acute tubular necrosis and collapsing focal segmental glomerulosclerosis, respectively." | 2.44 | Bisphosphonate nephrotoxicity. ( Markowitz, GS; Perazella, MA, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Roij van Zuijdewijn, C | 1 |
| van Dorp, W | 1 |
| Florquin, S | 1 |
| Roelofs, J | 1 |
| Verburgh, K | 1 |
| Perazella, MA | 1 |
| Markowitz, GS | 1 |
| Auron, A | 1 |
| Tal, L | 1 |
| Srivastava, T | 1 |
| Alon, US | 1 |
| Jotterand, V | 1 |
| Moll, S | 1 |
| Martin, PY | 1 |
| Saudan, P | 1 |
| Harbord, N | 1 |
| Omidvar, B | 1 |
| Ghorbani, A | 1 |
| Shahbazian, H | 1 |
| Beladi Mousavi, SS | 1 |
| Shariat Nabavi, SJ | 1 |
| Alasti, M | 1 |
| Hirschberg, R | 1 |
| Tokumoto, T | 1 |
| Tanabe, K | 1 |
| Toma, H | 1 |
| Akiba, T | 1 |
| Acott, PD | 1 |
| Wong, JA | 1 |
| Crocker, JF | 1 |
| Lang, B | 1 |
| O'Regan, P | 1 |
| Renton, KW | 1 |
| de Lemos, ML | 1 |
| Taylor, SC | 1 |
| Barnett, JB | 1 |
| Hu, F | 1 |
| Levin, A | 1 |
| Moravan, V | 1 |
| O'Reilly, SE | 1 |
6 reviews available for pamidronate and Kidney Diseases
| Article | Year |
|---|---|
Bisphosphonate nephropathy: A case series and review of the literature.
Topics: Animals; Diphosphonates; Humans; Imidazoles; Kidney Diseases; Pamidronate; Rats; Zoledronic Acid | 2021 |
Bisphosphonate nephrotoxicity.
Topics: Diphosphonates; Glomerulosclerosis, Focal Segmental; Humans; Imidazoles; Kidney Cortex Necrosis; Kid | 2008 |
[Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Diphosphonates; Female; Fractures, Spontaneous | 2009 |
Novel nephrotoxins.
Topics: Adenine; Alcohols; Angiogenesis Inhibitors; Anticonvulsants; Antipsychotic Agents; Dasatinib; Diphos | 2011 |
Renal complications from bisphosphonate treatment.
Topics: Acute Kidney Injury; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Kidney; Kidney Diseases; Ne | 2012 |
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds | 2004 |
2 trials available for pamidronate and Kidney Diseases
| Article | Year |
|---|---|
Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Alendronate; Anti-Inflammatory Agents; Bone Den | 2011 |
Pamidronate distribution in pediatric renal and rheumatologic patients.
Topics: Adolescent; Alkaline Phosphatase; Area Under Curve; Bone and Bones; Bone Density Conservation Agents | 2006 |
2 other studies available for pamidronate and Kidney Diseases
| Article | Year |
|---|---|
Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.
Topics: Acute Disease; Adolescent; Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates | 2009 |
Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Cost-Benefit Analysis; Crea | 2006 |